Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
FHTX
#2701
Foghorn Therapeutics Inc. Common Stock
5.680
0
+0.89%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.89%
Variazione Mensile
-3.97%
Variazione di 6 mesi
+39.22%
Variazione Annuale
+39.22%
Chiusura Precedente
5.630
0
Open
5.680
0
Bid
Ask
Low
5.680
0
High
5.680
0
Volume
33
Mercati
Mercato Azionario Statunitense
Salute
FHTX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
36.82 M
41.42 M
41.8 M
42.57 M
55.61 M
—
Valuation ratios
Enterprise value
653.48 M
846.18 M
219.51 M
194.21 M
207.04 M
729.79 M
Price to earnings ratio
—
-8.38
-2.48
-2.76
-2.99
-14.63
Price to sales ratio
—
644.51
14.06
7.93
11.46
44.83
Price to cash flow ratio
—
16.92
1.4
2.29
2.58
11.27
Price to book ratio
—
8.78
2 413.79
3.51
5.69
9.58
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.27
0.19
0.27
0.34
0.3
0.3
Return on equity %
0.47
1.05
972.32
1.27
1.9
1.14
Return on invested capital %
182.8
188.74
159.43
156.66
202.12
—
Gross margin %
100
100
100
100
100
400
Operating margin %
15.94 K
7 637.15
609.2
315.93
454.31
1 731.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
16 K
7 680.06
566.36
288.1
383.15
1 429.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.12
9.44
6.37
4.11
3.73
11.67
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.04
0.1
0.08
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0
—
—
—
—
Long term debt to total equity ratio
0.13
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.35
4.66
2.81
1.83
1.46
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.72
1.26
1.91
1.01
4.55
Net current asset value per share
—
12.36
8.45
5.72
4.55
14.29
Tangible book value per share
—
2.61
0
1.84
0.83
4.45
Working capital per share
—
11.05
7.12
4.33
3.33
9.35
Book value per share
—
2.61
0
1.84
0.83
4.45
Notizie
Foghorn Therapeutics nomina Ryan Maynard come direttore finanziario
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Jefferies initiates Foghorn Therapeutics stock with buy rating
I migliori titoli sanitari per quest’anno secondo BTIG
Top Healthcare Stocks for This Year According to BTIG
Azioni Foghorn Therapeutics riconfermate come Acquisto da BTIG, nominate top pick per il 1H26
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26
Stifel conferma il rating Buy sulle azioni di Foghorn Therapeutics con target di $12
Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12 target
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
BTIG avvia la copertura su Foghorn Therapeutics con rating Buy grazie alla pipeline oncologica
BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline